Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72701 - 72725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	RUNX2	860	upregulated	Silicon Dioxide analog results in increased expression of RUNX2 mRNA	6p21.1	A24195
Silicon dioxide	Approved	RUSC2	9853	upregulated	Silicon Dioxide results in increased expression of RUSC2 mRNA	9p13.3	A24196
Silicon dioxide	Approved	RWDD2B	10069	downregulated	Silicon Dioxide results in decreased expression of RWDD2B mRNA	21q21.3	A24196
Silicon dioxide	Approved	RYR1	6261	downregulated	Silicon Dioxide analog results in decreased expression of RYR1 mRNA	19q13.2	A24195
Silicon dioxide	Approved	S100A1	6271	downregulated	Silicon Dioxide analog results in decreased expression of S100A1 mRNA	1q21.3	A24195
Silicon dioxide	Approved	S100A3	6274	upregulated	Silicon Dioxide analog results in increased expression of S100A3 mRNA	1q21.3	A24194 A24195
Silicon dioxide	Approved	S100A7	6278	upregulated	Silicon Dioxide analog results in increased expression of S100A7 mRNA	1q21.3	A24194
Silicon dioxide	Approved	S100P	6286	downregulated	Silicon Dioxide analog results in decreased expression of S100P mRNA	4p16.1	A24195
Silicon dioxide	Approved	SAA1	6288	upregulated	Silicon Dioxide analog results in increased expression of SAA1 mRNA	11p15.1	A24195
Silicon dioxide	Approved	SAG	6295	upregulated	Silicon Dioxide analog results in increased expression of SAG mRNA	2q37.1	A24194
Silicon dioxide	Approved	SAGE1	55511	upregulated	Silicon Dioxide analog results in increased expression of SAGE1 mRNA	Xq26.3	A24195
Silicon dioxide	Approved	SALL2	6297	downregulated	Silicon Dioxide analog results in decreased expression of SALL2 mRNA	14q11.2	A24195
Silicon dioxide	Approved	SAMD13	148418	downregulated	Silicon Dioxide analog results in decreased expression of SAMD13 mRNA	1p31.1	A24195
Silicon dioxide	Approved	SAMD4A	23034	upregulated	Silicon Dioxide analog results in increased expression of SAMD4A mRNA	14q22.2	A24195
Silicon dioxide	Approved	SAMD4A	23034	upregulated	Silicon Dioxide results in increased expression of SAMD4A mRNA	14q22.2	A24196
Silicon dioxide	Approved	SAMD5	389432	upregulated	Silicon Dioxide analog results in increased expression of SAMD5 mRNA	6q24.3	A24194
Silicon dioxide	Approved	SAMD9L	219285	downregulated	Silicon Dioxide analog results in decreased expression of SAMD9L mRNA	7q21.2	A24195
Silicon dioxide	Approved	SARM1	23098	downregulated	Silicon Dioxide analog results in decreased expression of SARM1 mRNA	17q11.2	A24195
Silicon dioxide	Approved	SASH1	23328	upregulated	Silicon Dioxide results in increased expression of SASH1 mRNA	6q24.3-q25.1	A24196
Silicon dioxide	Approved	SAT1	6303	upregulated	Silicon Dioxide analog results in increased expression of SAT1 mRNA	Xp22.11	A24195
Silicon dioxide	Approved	SBDS	51119	upregulated	Silicon Dioxide analog results in increased expression of SBDS mRNA	7q11.21	A24195
Silicon dioxide	Approved	SBSPON	157869	downregulated	Silicon Dioxide analog results in decreased expression of SBSPON mRNA	8q21.11	A24195
Silicon dioxide	Approved	SCAND2P	54581	downregulated	Silicon Dioxide results in decreased expression of SCAND2P mRNA	15q25.2	A24196
Silicon dioxide	Approved	SCARA5	286133	downregulated	Silicon Dioxide analog results in decreased expression of SCARA5 mRNA	8p21.1	A24195
Silicon dioxide	Approved	SCD5	79966	downregulated	Silicon Dioxide analog results in decreased expression of SCD5 mRNA	4q21.22	A24195

Displaying entries 72701 - 72725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability